Page last updated: 2024-10-25

ciprofloxacin and Cancer of Mediastinum

ciprofloxacin has been researched along with Cancer of Mediastinum in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jarfaut, A1
Santucci, R1
Levêque, D1
Herbrecht, R1
Pishvaian, AC1
Collins, B1
Gagnon, G1
Ahlawat, S1
Haddad, NG1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Comparison of Traditional Back-loaded Fiducial Needles With Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement for Image-guided Radiation Therapy in Patients With Pancreatic Cancer: A Multicenter Randomized Controlled Trial.[NCT02332863]44 participants (Actual)Interventional2016-08-03Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Number of Fiducials Placed

Number of fiducials placed will be recorded during the procedure using a case report form (CRF) for Fiducial Placement Data (NCT02332863)
Timeframe: During scheduled procedure (about 90 minutes)

Interventionfiducials (Median)
Back-loaded Needle3
Preloaded Needle3

Number of Participants With Inadvertent Deployment of Fiducials

Whether inadvertent deployment of fiducials occurs will be recorded on a CRF for Data Acquisition (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)

InterventionParticipants (Count of Participants)
Back-loaded Needle1
Preloaded Needle1

Number of Participants With Technical Success EUS Needle Visualization

EUS needle visualization during the procedure will be recorded on a CRF for Scale of Technical Success. (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)

InterventionParticipants (Count of Participants)
Back-loaded Needle16
Preloaded Needle14

Number of Participants With Visualization of Fiducials as Assessed by Radiation Oncology

Fiducial location on CT scan will be assessed at patient's radiation oncology appointments for IGRT. (NCT02332863)
Timeframe: Several hours to 7 days after fiducial marker deployment

InterventionParticipants (Count of Participants)
Back-loaded Needle20
Preloaded Needle19

Procedure Duration Required for Placing the Fiducial Markers

Duration of procedure for placing fiducial markers including: Fiducial package was opened start time (start stop watch) + Fiducial placement end time (end stop watch) = Placing Fiducial Markers Time (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)

Interventionmintues (Median)
Back-loaded Needle16
Preloaded Needle9

Technical Success

Defined as the proper placement of 3 fiducial markers in a pancreatic neoplasm in 2 different planes (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)

InterventionParticipants (Count of Participants)
Back-loaded Needle22
Preloaded Needle20

Total Procedure Time

Total procedure time will be recorded during the procedure using a case report form (CRF) for Procedure Time (NCT02332863)
Timeframe: During scheduled procedure (approximately 1 hour)

Interventionminutes (Median)
Back-loaded Needle27
Preloaded Needle25

Other Studies

2 other studies available for ciprofloxacin and Cancer of Mediastinum

ArticleYear
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
    Medecine et maladies infectieuses, 2013, Volume: 43, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Ant

2013
EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies.
    Gastrointestinal endoscopy, 2006, Volume: 64, Issue:3

    Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prop

2006